CITIC Private Equity Funds Management is the strategic onshore private equity platform of CITIC Group and CITIC.
Business Model:
Revenue: $0
Employees: 0-0
Address: 11/F Jinbao Tower
City: Dongcheng District
State: beijing municipality
Zip: 100005
Country: CN
CPE is a leading alternative asset manager, with asset classes spanning private equity, mezzanine and the public market. Founded in 2008 by a world class team of investment professionals and supported by over 200 domestic and international investors, CPE knows China like no one else and is a globally minded long-term value investor. The firm uses its sector expertise to generate deal flow and drive the value creation work during the post-investment stage. CPE follows a disciplined investment approach to preserve and grow its investors’ capital. The firm’s private equity portfolio of more than 100 companies is highly diversified by sector and stage of investment. CPE takes pride in its forward-looking investment philosophy and works hard to create value over the long-term for its investors and a better world. For more information, please visit www.citicpe.com.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2021 | Mixuebingcheng | Series A | 309.2M |
10/2016 | ofo | Series C | 130M |
7/2017 | ofo | Series E | 700M |
5/2021 | MissBerry Berry Sweetheart | Series A | 0 |
6/2021 | Triastek | Series B | 0 |
10/2021 | Dreame Technology | Series C | 0 |
5/2018 | CStone Pharmaceuticals | Series B | 260M |
5/2021 | Opnous | Series B | - |
2/2021 | Didi Freight | Series A | 0 |
7/2011 | VANCL | Series F | 230M |
1/2021 | Enflame | Series C | 278.8M |
9/2021 | MissBerry Berry Sweetheart | Venture Round | 1.6M |
9/2016 | guanaitong.com | Private Equity Round | 20.2M |
10/2020 | 3D Medicines | Private Equity Round | 0 |
1/2021 | 4Paradigm | Series D | 0 |
8/2022 | Jinyuansheng | Series B | 147.6M |
6/2018 | Deerma | Series A | 76.5M |
12/2018 | Adaps Photonics | Angel Round | 431.1k |
2/2014 | Cheyipai | Series C | 50M |
1/2022 | SiBionics | Series C | 0 |
1/2010 | CHINA UNION LOYALTY | Series A | 2.9M |
4/2015 | ZHONGHE PHARMACEUTICAL | Funding Round | 8.1M |
11/2014 | Zhongce Che Kongjian | Series B | 3.2M |
3/2018 | 17zuoye | Series E | 250M |
5/2019 | JD Health | Series A | 1B |
12/2021 | Lumous Intelligence | Series B | - |
6/2021 | Hesai Technology | Series D | 300M |
12/2017 | Jiaanpei | Venture Round | 0 |
11/2021 | Zhihe Technology | Series B | - |
3/2017 | ofo | Series D | 450M |
3/2016 | FXiaoKe | Series E | - |
9/2021 | Mol Breeding | Series A | 1.6M |
7/2021 | Cloudwise | Series E | 150M |
11/2021 | Hesai Technology | Series D | 70M |
4/2010 | Happigo | Series A | 43.9M |
5/2021 | Rapid Medical | Series D | 50M |
1/2021 | Synlight Crystal | Series C | - |
11/2021 | GTA Semiconductor | Venture Round | 0 |
3/2022 | XVERSE | Series A | 120M |
9/2020 | Fiture | Series A | 0 |
2/2021 | Wangjiahuan | Series B | 123.8M |
3/2021 | Kunlun | Venture Round | - |
9/2013 | G-NET | Angel Round | 489.6k |
4/2020 | MicroPort CardioFlow | Private Equity Round | 130M |
3/2021 | ThreatBook | Series E | 76.9M |
11/2021 | Ustar | Series E | 47.1M |
6/2011 | New China Life Insurance | Venture Round | - |
6/2021 | Insilico Medicine | Series C | 0 |
11/2009 | China UnionPay Merchant Services | Series C | - |
5/2021 | Hangzhou DAC Biotech Co., Ltd | Series C | 154.9M |
6/2015 | Touch | Series B | 13.7M |
5/2021 | Weilong Foods | Series A | 558M |
4/2021 | Shumei Technology | Series D | 135M |
7/2021 | TransThera Biosciences | Series D | 100M |
1/2021 | Horizon Robotics | Series C | 0 |
2/2021 | Shanghai ANE Logistics | Private Equity Round | 300M |
9/2016 | Best | Private Equity Round | 0 |
12/2020 | Lumous Intelligence | Series A | - |
4/2021 | Fiture | Series B | 0 |
8/2021 | JOINN Biologics | Series B | 150M |
11/2021 | Sepax Technologies | Series D | 0 |
1/2010 | Red Star Macalline | Private Equity Round | 380.7M |
8/2020 | MicroPort EP | Private Equity Round | 43.1M |
7/2017 | Terminus Technologies | Series A | 73.5M |
3/2021 | Biotheus | Equity | 100M |
6/2020 | JW Therapeutics | Series B | 0 |
10/2021 | Wangdiantong | Series D | 312M |
1/2021 | Geek+ | Series D | - |
10/2020 | Yuanfudao | Series G | 0 |
1/2015 | ELEME | Series E | 350M |
12/2021 | Chipone Technology | Series E | 0 |
7/2021 | Synlight Crystal | Series E | - |
6/2021 | Biocytogen | Series E | - |
5/2019 | Chuangmi Technology | Series A | 0 |
9/2010 | Shaanxi Xifeng Liquor Co,.LTD | Angel Round | 448.3k |
4/2022 | Reliable Med | Series A | 15M |
9/2021 | HiScene | Series C | 0 |
6/2021 | Banu Hotpot | Venture Round | 77.3M |
9/2020 | DuerOS | Series A | 294.5M |
3/2021 | Biotheus | Series B | - |
1/2021 | Jaka Robot | Series C | 46.3M |
3/2019 | Servyou Group | Angel Round | 446.9k |
2/2021 | Pony.ai | Series C | 0 |
8/2020 | Hanyu Medical | Series D | 0 |
2/2021 | Fenbi | Series A | 390M |
9/2020 | MicroPort Medbot | Private Equity Round | 512.4M |
1/2021 | Didi Woya | Series A | 0 |
9/2011 | Green A | Series B | 15.7M |
1/2016 | Fengbang Leasing | Series D | 45.7M |
4/2022 | Reliable Med | Series A | 0 |
3/2022 | XVERSE | Series A | 0 |
1/2022 | SiBionics | Series C | 0 |
12/2021 | Lumous Intelligence | Series B | - |
12/2021 | Chipone Technology | Series E | 0 |
11/2021 | GTA Semiconductor | Venture Round | 0 |
11/2021 | Ustar | Series E | 0 |
11/2021 | Hesai Technology | Series D | 0 |
11/2021 | Sepax Technologies | Series D | 0 |
11/2021 | Zhihe Technology | Series B | - |
Name | Price |
---|
Name | Size | Announced Date |
---|